CID 45101966

3''-deamino-3''-hydroxykanamycin c(3+)

Structural Information

Molecular Formula
C18H35N3O12
SMILES
C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)N)N
InChI
InChI=1S/C18H35N3O12/c19-4-1-5(20)16(33-18-13(28)12(27)10(25)7(3-23)31-18)14(29)15(4)32-17-8(21)11(26)9(24)6(2-22)30-17/h4-18,22-29H,1-3,19-21H2/t4-,5+,6+,7+,8+,9+,10+,11+,12-,13+,14-,15+,16-,17+,18+/m0/s1
InChIKey
UPPJKCYSMDGLRE-DNBVWFFRSA-N
Compound name
(2S,3R,4S,5S,6R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

8
Patents

485.22208 Da
Monoisotopic Mass

-6.7
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 486.22936 210.5
[M+Na]+ 508.21130 210.5
[M-H]- 484.21480 201.8
[M+NH4]+ 503.25590 209.9
[M+K]+ 524.18524 214.1
[M+H-H2O]+ 468.21934 201.3
[M+HCOO]- 530.22028 212.2
[M+CH3COO]- 544.23593 216.8
[M+Na-2H]- 506.19675 239.5
[M]+ 485.22153 212.9
[M]- 485.22263 212.9
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe